GlaxoSmithKline Pharmaceuticals has reported results for third quarter ended December 31, 2016.
The company has reported 32.92% fall in its net profit at Rs 52.95 crore for the quarter under review as compared to Rs 78.93 crore for the same quarter in the previous year. Total income of the company decreased by 7.21% at Rs 721.15 crore for the quarter under review as compared Rs 777.16 crore for the corresponding quarter previous year.
GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.
